| Financial Year |
March 31 2023 |
| Monetary Funds |
894,452,315.03 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
198,527,803.19 |
| Accounts Receivable |
2,727,808,381.49 |
| Advances to Suppliers |
11,925,951.17 |
| Other Receivables |
26,905,736.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,232,747,120.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
155,792,309.56 |
| Total Current Assets |
6,944,774,989.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
520,093,578.98 |
| Investment Properties |
231,271,362.67 |
| Fixed Assetes |
213,148,099.44 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,257,506.91 |
| R&D expenses |
15,556,573.29 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,887,001.83 |
| Deferred Income Tax Assets |
49,292,282.02 |
| Other Non-Current Assets |
1,746,050.26 |
| Sub-Total of Non-Current Assets |
1,133,135,896.03 |
| Total Assets |
8,077,910,885.78 |
| Short-Term Loans |
23,017,777.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
345,781,730.84 |
| Accounts Payable |
1,700,709,501.70 |
| Accounts Received In Advance |
1,478,660.80 |
| Employee Compensation Payable |
14,468,005.66 |
| Taxes Payable |
30,257,897.09 |
| Interest Payable |
-- |
| Dividend Payable |
1,894,437.47 |
| Other payables |
31,509,354.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,663,976.01 |
| Other Current Liabilities |
79,469,413.49 |
| Sub-Total of Current Liabilities |
2,761,300,641.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
29,622,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,662,454.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
80,105,901.83 |
| Total Liabilities |
2,841,406,543.47 |
| Paid-In Capital(Or Share Stock) |
1,241,857,840.00 |
| Capital Surplus |
1,804,703,818.43 |
| Surplus Reserve |
157,592,863.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,000,579,299.14 |
| Minority Stockholder's Interest |
16,735,634.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,219,768,707.66 |
| Owner's Equity（Stockholder's Equity） |
5,236,504,342.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,077,910,885.78 |
